Zhang Chao, Wang Qing-Tao, Liu He, Zhang Zhen-Zhu, Huang Wen-Lin
Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.
Chin J Cancer. 2011 Mar;30(3):182-8. doi: 10.5732/cjc.010.10074.
Gene therapy is one of the most attractive fields in tumor therapy. In past decades, significant progress has been achieved. Various approaches, such as viral and non-viral vectors and physical methods, have been developed to make gene delivery safer and more efficient. Several therapeutic strategies have evolved, including gene-based (tumor suppressor genes, suicide genes, antiangiogenic genes, cytokine and oxidative stress-based genes) and RNA-based (antisense oligonucleotides and RNA interference) approaches. In addition, immune response-based strategies (dendritic cell- and T cell-based therapy) are also under investigation in tumor gene therapy. This review highlights the progress and recent developments in gene delivery systems, therapeutic strategies, and possible clinical directions for gene therapy.
基因治疗是肿瘤治疗中最具吸引力的领域之一。在过去几十年里,已经取得了重大进展。人们开发了各种方法,如病毒载体和非病毒载体以及物理方法,以使基因传递更安全、更有效。几种治疗策略也得到了发展,包括基于基因的(肿瘤抑制基因、自杀基因、抗血管生成基因、细胞因子和基于氧化应激的基因)和基于RNA的(反义寡核苷酸和RNA干扰)方法。此外,基于免疫反应的策略(基于树突状细胞和T细胞的治疗)也正在肿瘤基因治疗中进行研究。本综述重点介绍了基因传递系统、治疗策略以及基因治疗可能的临床方向的进展和最新发展情况。